Skip to main content

Hanson & Doremus Investment Management

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1393944 BURLINGTON, VT

Position in VRTX

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$265,253
+$17,870 QoQ
Shares Held
534
-3.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,287
of 1,735 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Hanson & Doremus Investment Management holds $275,229 across 2 Biotechnology names. VRTX ranks #1 (96.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
534 $265,253

All Filings in VRTX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $265,253 534
2026-03-31 $247,383 554
2025-12-31 $251,161 554
2025-09-30 $209,135 534
2025-06-30 $253,764 570
2025-03-31 $179,383 370
2024-12-31 $28,189 70
2024-09-30 $32,555 70
2024-06-30 $32,810 70
2024-03-31 $29,260 70
2023-12-31 $28,482 70
2023-09-30 $26,080 75
2023-06-30 $26,393 75
2023-03-31 $23,630 75
2022-12-31 $21,658 75
2022-09-30 $21,715 75
2021-03-31 $1,504 7